02065nam 2200553 450 991079228820332120230803024305.01-78084-228-7(CKB)2560000000152108(EBL)1179640(SSID)ssj0001599924(PQKBManifestationID)16306517(PQKBTitleCode)TC0001599924(PQKBWorkID)14892692(PQKB)10870922(MiAaPQ)EBC1179640(Au-PeEL)EBL1179640(OCoLC)877767288(EXLCZ)99256000000015210820220517d2013 uy 0engur|n|---|||||txtccrCurrent & emerging therapeutics for multiple myeloma /editors, Noopur Raje, Sundar Jagannath1st ed.London, England :Future Medicine Ltd.,[2013]©20131 online resource (141 p.)Description based upon print version of record.1-78084-230-9 Title page; Copyright page; Contents; Foreword. Current and emerging therapeutics for multiple myeloma; 1. Current standard treatment of myeloma; 2. Stem cell transplantation; 3. New immune modulators; 4. Histone deacetylase inhibitors; 5. Targeted treatment of multiple myeloma: proteasome inhibitors; 6. AKT inhibitors in multiple myeloma; 7. Future directions; IndexCurrent & Emerging Therapeutics for Multiple MyelomaCurrent and emerging therapeutics for multiple myelomaMultiple myelomaTreatmentMultiple myelomaChemotherapyMultiple myelomaTreatment.Multiple myelomaChemotherapy.616.99418Raje NoopurJagannath SundarMiAaPQMiAaPQMiAaPQBOOK9910792288203321Current & emerging therapeutics for multiple myeloma3851828UNINA